Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel To Monitor Treatment Journey for Patients With Traumatic Brain Injury and Alzheimer’s
UF Innovate's funding institution Gryphon Bio, Inc. is pursuing observational clinical studies with U.S. and international partners to validate a novel blood biomarker panel for early detection and monitoring of TBI and Alzheimer’s disease.
Abbott Blood Test To Evaluate Mild Concussions Wins FDA Clearance
Doctors soon will have a new way to evaluate patients with concussions: a rapid blood test made by Abbott Laboratories that has been cleared by the U.S. Food and Drug Administration. It’s an advancement that could eliminate the need for some patients to get costly CT scans and the radiation exposure that accompanies them.
